Indefinite Delivery Contract 75N91023D00007
- Not listed
- This single-award IDV was issued by the National Cancer Institute, part of the Department of Health and Human Services, on April 11, 2023 with a potential value of $12.1 million. The contract aims to procure analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations to support the Institute's research efforts. Research Triangle Institute was selected as the prime contractor to deliver the required products and services over a five-year ordering period ending April 10,...
- This federal Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $49,990,000 single-award IDC has an ultimate completion date of June 30, 2028 and does not have a set-aside designation. Under this IDC, Mriglobal is providing a range of scientific research, testing, and product...
- The contract IDV award is for the PREVENT Cancer Preclinical Drug Development Program, a multiple-award IDIQ contract administered by the National Cancer Institute (NCI). The program encompasses three main technical areas: (1) evaluation of the efficacy and pharmacodynamic/efficacy biomarkers for potential cancer preventive agents, (2) preclinical product development, analytical testing, process development, and cGMP manufacturing support for cancer preventive vaccines, and (3) pharmacological...
- The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services. The single-award contract, valued at a ceiling of $50,000,000, was awarded to the non-profit research organization Research Triangle Institute (RTI International) on September 15, 2025, with a period of performance extending until September 14, 2032. The contract is for...
- This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide Biomedical Information Management and Analytic Support Services. The multiple award IDV has a potential value of $148 million over five years. Task orders issued to date include $1.56 million for data analytics, statistical analysis and bioinformatics support for genome-wide association studies under cost plus fixed fee pricing to...
- The federal contract IDV is an Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH). The prime contractor is the Public Health Institute (PHI), a non-profit organization. The IDC, valued at $275,000,000, is for the Surveillance, Epidemiology, and End Results (SEER) program, which conducts cancer epidemiology research and surveillance. Under this IDC, PHI...
- This indefinite delivery contract (IDC) was awarded by a U.S. federal government agency to IIT Research Institute (IITRI), a non-profit contract research organization. The IDC is a multiple-award vehicle with a $0 ceiling value and an ultimate completion date of September 30, 2007. Under this IDC, IITRI provides a range of preclinical research services to support federal agencies such as the National Institutes of Health (NIH), including the National Cancer Institute (NCI), National Institute of...
- The federal contract IDV award GS10F0127J is a Federal Supply Schedule (FSS) contract, a multiple award vehicle that allows for rapid procurement of diverse services from the prime contractor, Mriglobal (doing business as Midwest Research Institute). Mriglobal is a 501(c)(3) not-for-profit research organization that supports federal agencies such as the Department of Health and Human Services, Department of Defense, and Department of Homeland Security with a range of scientific research,...
- This indefinite delivery contract was awarded by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the non-profit research and development institute SRI International. The single-award contract, valued at a ceiling of $12,069,385, is for the analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. With a period of performance running through April 2028, this contract enables the National Cancer Institute to efficiently...
- The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the non-profit research and development organization SRI International. The single-award contract has a $50,000,000.00 ceiling value and a performance period through September 14, 2032. The contract is for INTERVENTIONAL AGENTS CHEMISTRY SERVICES, providing SRI International's specialized research and technical capabilities to the...
The multiple award IDV was issued by the National Cancer Institute, within the Department of Health and Human Services' National Institutes of Health, to provide analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. Mriglobal, doing business as Midwest Research Institute, was awarded the IDV with a potential value of $12.1M and a period of performance through April 2028. The IDV facilitates the placement of task orders for preclinical and clinical development services, including analytical method development and validation, synthesis of drug substances and products, formulation development, stability testing, and regulatory support. These services will support the National Cancer Institute's cancer research programs by expediting the translation of basic discoveries into clinical applications through pre-IND enabling studies and early phase clinical trials. The multiple award structure of the IDV enables the agency to obtain these critical preclinical and clinical development services from Mriglobal on an as-needed basis over the five year ordering period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 6/29/23 | |
| Not listed | Not listed | $0 | 4/10/23 |